Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mohammed Alkhaldi, Aisha Al Basuoni, Márcia Matos, Marcel Tanner & Sara Ahmed. (2021) Health Technology Assessment in High, Middle, and Low-income Countries: New Systematic and Interdisciplinary Approach For Sound Informed-policy Making: Research Protocole. Risk Management and Healthcare Policy 14, pages 2757-2770.
Read now
Read now
Bertalan Németh, Wim Goettsch, Finn Børlum Kristensen, Oresta Piniazhko, Mirjana Huić, Tomáš Tesař, Dragana Atanasijevic, Iga Lipska & Zoltán Kaló. (2020) The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research 20:4, pages 321-330.
Read now
Read now
Dávid Dankó & Guenka Petrova. (2014) Health technology assessment in the Balkans: opportunities for a balanced drug assessment system. Biotechnology & Biotechnological Equipment 28:6, pages 1181-1189.
Read now
Read now
Articles from other publishers (12)
Songul Cinaroglu & Busra Saylan. 2023. Using Crises and Disasters as Opportunities for Innovation and Improvement. Using Crises and Disasters as Opportunities for Innovation and Improvement
248
267
.
Mengmeng Zhang, Yun Bao, Yi Yang, Melissa Kimber, Mitchell Levine & Feng Xie. (2023) Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study. PharmacoEconomics 41:4, pages 439-455.
Crossref
Crossref
Yu-Shan Wu, Chiehfeng Chen, Lin-Chien Wang, Li-Shan Jian & Yu Ko. (2022) Talent cultivation in health technology assessment: an expert survey. BMC Medical Education 22:1.
Crossref
Crossref
Srđan Lučić, Lejla Gurbeta Pokvić, Ervina Bečić & Almir Badnjević. 2021. CMBEBIH 2021. CMBEBIH 2021
547
553
.
Tracy A. Comans, Kim-Huong Nguyen, Julie Ratcliffe, Donna Rowen & Brendan Mulhern. (2020) Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff. PharmacoEconomics 38:8, pages 871-881.
Crossref
Crossref
Bertalan Németh & Zoltán Kaló. (2020) European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries. Journal of Comparative Effectiveness Research 9:9, pages 599-602.
Crossref
Crossref
T. I. Armina Padmasawitri, Sarah Maria Saragih, Gerardus W. Frederix, Olaf Klungel & Anke M. Hövels. (2019) Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review. PharmacoEconomics - Open 4:2, pages 223-233.
Crossref
Crossref
Gordon Liu, Eric Q. Wu, Jeonghoon Ahn, Isao Kamae, Jipan Xie & Hongbo Yang. (2020) The Development of Health Technology Assessment in Asia: Current Status and Future Trends. Value in Health Regional Issues 21, pages 39-44.
Crossref
Crossref
Ahmad Fasseeh, Rita Karam, Mouna Jameleddine, Mohsen George, Finn Børlum Kristensen, Abeer A. Al-Rabayah, Abdulaziz H. Alsaggabi, Maha El Rabbat, Maryam S. Alowayesh, Julia Chamova, Adham Ismail, Sherif Abaza & Zoltán Kaló. (2020) Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status. Frontiers in Pharmacology 11.
Crossref
Crossref
Mónica D. Oliveira, Inês Mataloto & Panos Kanavos. (2019) Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art. The European Journal of Health Economics 20:6, pages 891-918.
Crossref
Crossref
Tomas Tesar, Branislav Obsitnik, Zoltán Kaló & Finn Børlum Kristensen. (2019) How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia. Frontiers in Pharmacology 10.
Crossref
Crossref
D. Rodin, A. Aggarwal, Y. Lievens & R. Sullivan. (2017) Balancing Equity and Advancement: The Role of Health Technology Assessment in Radiotherapy Resource Allocation. Clinical Oncology 29:2, pages 93-98.
Crossref
Crossref